| 000 | 01742 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514233659.0 | ||
| 264 | 0 | _c20050825 | |
| 008 | 200508s 0 0 eng d | ||
| 022 | _a1535-6108 | ||
| 024 | 7 |
_a10.1016/j.ccr.2005.06.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTao, Weikang | |
| 245 | 0 | 0 |
_aInduction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage. _h[electronic resource] |
| 260 |
_bCancer cell _cJul 2005 |
||
| 300 |
_a49-59 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 | _aCaspase 3 |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 |
_aCell Cycle Proteins _xmetabolism |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGenes, cdc _xphysiology |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKinesins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMitosis _xdrug effects |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aProtein Kinases _xmetabolism |
| 650 | 0 | 4 | _aProtein Serine-Threonine Kinases |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
| 650 | 0 | 4 |
_aPyrroles _xpharmacology |
| 650 | 0 | 4 |
_aSpindle Apparatus _xphysiology |
| 650 | 0 | 4 | _abcl-2-Associated X Protein |
| 700 | 1 | _aSouth, Victoria J | |
| 700 | 1 | _aZhang, Yun | |
| 700 | 1 | _aDavide, Joseph P | |
| 700 | 1 | _aFarrell, Linda | |
| 700 | 1 | _aKohl, Nancy E | |
| 700 | 1 | _aSepp-Lorenzino, Laura | |
| 700 | 1 | _aLobell, Robert B | |
| 773 | 0 |
_tCancer cell _gvol. 8 _gno. 1 _gp. 49-59 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ccr.2005.06.003 _zAvailable from publisher's website |
| 999 |
_c15678802 _d15678802 |
||